New ProductsView all New Products Alphabetically
Search for new products by date added, alphabetically, or by pharmacological action.
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the New symbol.
If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.
| Cat. No. | Product Name / Activity | Date Added |
|---|---|---|
| 6297 | AP 20187 | Aug 2020 |
| Chemical inducer of protein dimerization; active in vivo | ||
| 7254 | ARCC 4 | Nov 2020 |
| Potent and selective androgen receptor degrader | ||
| 7255 | ARCC 4 negative control | Nov 2020 |
| Negative control for ARCC 4 (Cat. No. 7254) | ||
| 7370 | 3-Aminotyrosine | Dec 2020 |
| Unnatural amino acid for inducing red shift in fluorescent proteins and fluorescent protein-based biosensors | ||
| 7283 | Apilimod dimesylate | Aug 2020 |
| Potent and selective PIKfyve inhibitor | ||
| 6562 | BAY 707 | Dec 2020 |
| Potent and selective MTH1 inhibitor | ||
| 7377 | BIIE 0246 hydrochloride | Dec 2020 |
| Potent, selective and competitive non-peptide NPY Y2 receptor antagonist; active in vivo | ||
| 6996 | BOP-JF549 | Sep 2020 |
| Yellow fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 549; fluorogenic; photostable | ||
| 6997 | BOP-JF646 | Aug 2020 |
| Red fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 646; fluorogenic; photostable | ||
| 7282 | Bortezomib | Jan 2021 |
| High affinity proteasome inhibitor | ||
| 7273 | C-Laurdan | Jan 2021 |
| Two-photon polarity-sensitive lipid membrane probe | ||
| 7219 | CRBN PROTAC® 14a | Oct 2020 |
| Cereblon Degrader | ||
| 7188 | Carfilzomib | Oct 2020 |
| Potent irreversible proteasome inhibitor; active in vivo | ||
| 7285 | DCLK1-IN-1 | Oct 2020 |
| Potent and selective doublecortin like kinase 1/2 (DCLK1/2) inhibitor; orally bioavailable | ||
| 7175 | DOPE | Jan 2021 |
| Liposome/lipoplex transfection reagent | ||
| 7193 | Deschloroclozapine | Oct 2020 |
| High affinity and highly potent activator of hM3Dq and hM4Di DREADDs; rapidly blood brain barrier penetrant | ||
| 7231 | EIDD 1931 | Aug 2020 |
| Viral RNA-dependent RNA polymerase (RdRP) inhibitor; broad spectrum antiviral nucleotide | ||
| 7199 | (±)-Eriodictyol | Oct 2020 |
| Potent TRPV1 antagonist; also antioxidant; activates Nrf2/ARE signaling | ||
| 5950 | Ethyl LipotF | Oct 2020 |
| Selective FTO inhibitor | ||
| 7287 | FAM-DEALA-Hyp-YIPD | Sep 2020 |
| Fluorescent HIF-1α peptide; can be used to evaluate the effect of VHL binding on degradation activity | ||
| 7158 | FMF-04-159-2 | Sep 2020 |
| Potent covalent CDK14 and CDK16 inhibitor; also inhibits other TAIRE kinase family members | ||
| 7159 | FMF-04-159-R | Sep 2020 |
| Potent CDK14 and CDK16 inhibitor; displays reversible inhibition of CDK14 | ||
| 7290 | Famotidine | Aug 2020 |
| Potent and high affinity H2 biased inverse agonist | ||
| 7059 | GLPG 0187 | Oct 2020 |
| Potent αv integrin inhibitor | ||
| 7280 | GRL 0617 | Aug 2020 |
| Coronavirus PLpro inhibitor | ||
| 7029 | GX 201 | Aug 2020 |
| Potent and selective Nav1.7 blocker; analgesic | ||
| 7258 | Gefitinib-based PROTAC® 3 | Nov 2020 |
| Potent EGFR Degrader | ||
| 7170 | D-GsMTx4 | Aug 2020 |
| TRPC1/6 and Piezo2 inhibitor; resistant to proteolytic digestion | ||
| 7277 | HBC 530 | Sep 2020 |
| GFP fluorophore mimic for imaging RNA in live cells; activated by binding to Pepper aptamers; suitable for confocal and two-photon microscopy | ||
| 7312 | HM Janelia Fluor® 526, SE | Dec 2020 |
| Spontaneously blinking green-emitting dye for SMLSM; λabsλem 526/550 nm | ||
| 7197 | JHU 37152 | Nov 2020 |
| High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | ||
| 7198 | JHU 37160 | Nov 2020 |
| High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | ||
| 7279 | Janelia Fluor® 646, Tetrazine | Sep 2020 |
| Red dye (Reactive group: tetrazine). Applications: super-resolution microscopy e.g. dSTORM & STED, confocal and live cell imaging | ||
| 6789 | K 03861 | Jul 2020 |
| Potent Cdk2 inhibitor | ||
| 7338 | K 22 | Dec 2020 |
| Inhibits coronavirus RNA replication; impairs double membrane vesicle (DMV) formation | ||
| 7178 | LCL 161, phenol | Sep 2020 |
| Functionalized IAP ligand for PROTACs | ||
| 6322 | LW 6 | Nov 2020 |
| Malate dehydrogenase-2 (MDH2) inhibitor; also inhibits HIF-1α | ||
| 7075 | Lenalidomide 4'-PEG1-amine | Sep 2020 |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | ||
| 7093 | Lenalidomide 4'-PEG2-amine | Aug 2020 |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | ||
| 7076 | Lenalidomide 4'-PEG3-amine | Sep 2020 |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | ||
| 7228 | MPro 13b | Dec 2020 |
| Coronavirus Mpro inhibitor | ||
| 7353 | MSA 2 | Dec 2020 |
| Non-nucleotide STING agonist; orally bioavailable | ||
| 7091 | Miro1 Reducer | Aug 2020 |
| Promotes mitochondrial Rho GTPase 1 (Miro1) degradation | ||
| 5927 | NS 383 | Nov 2020 |
| ASIC blocker; active in vivo | ||
| 6238 | PKRA 7 | Sep 2020 |
| Potent prokineticin (PK) 1 and 2 receptor antagonist; antitumor; BBB penetrant | ||
| 7357 | PLpro inhibitor 6 | Oct 2020 |
| SARS-CoV and SARS-CoV-2 PLpro inhibitor | ||
| 7212 | Pomalidomide 4'-PEG2-acid | Jul 2020 |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | ||
| 7213 | Pomalidomide 4'-PEG4-acid | Nov 2020 |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | ||
| 7095 | Pomalidomide 4'-PEG5-acid | Sep 2020 |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | ||
| 7209 | Pomalidomide 4'-alkylC4-acid | Aug 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 6990 | SET 2 | Dec 2020 |
| Selective TRPV2 antagonist | ||
| 7182 | SGC 6870 | Dec 2020 |
| Potent and selective PRMT6 inhibitor | ||
| 7184 | SGC 6870N | Dec 2020 |
| Negative control for SGC 6870 (Cat. No. 7182) | ||
| 7261 | SJF 1521 | Sep 2020 |
| Selective EGFR Degrader | ||
| 7262 | SJF 1528 | Sep 2020 |
| Potent EGFR Degrader; also degrades HER2 | ||
| 7266 | SJF 8240 | Dec 2020 |
| c-MET Degrader; also degrades exon-14-deleted c-MET | ||
| 7268 | SJFα | Jan 2021 |
| Potent and selective p38α degrader | ||
| 7267 | SJFδ | Dec 2020 |
| Potent and selective p38δ degrader | ||
| 7192 | SMIP 004 | Jan 2021 |
| SKP2 (S-phase kinase-associated protein 2) inhibitor; upregulates p27 and arrests cell cycle in G1 phase | ||
| 7322 | SP 10 | Dec 2020 |
| Highly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction | ||
| 7191 | Santacruzamate A | Sep 2020 |
| Highly potent and selective HDAC2 inhibitor | ||
| 7189 | Saracatinib | Aug 2020 |
| Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable | ||
| 7302 | Sulfo-NHS-LC-Biotin | Nov 2020 |
| Amine reactive biotinylation reagent, cell impermeable | ||
| 7259 | TBK1 PROTAC® 3i | Nov 2020 |
| Potent TANK-binding kinase 1 (TBK1) Degrader | ||
| 7260 | TBK1 control PROTAC® 4 | Nov 2020 |
| Negative control for TBK1 PROTAC® 3i (Cat. No. 7259) | ||
| 7131 | TM 38837 | Dec 2020 |
| Highly potent CB1 inverse agonist; peripherally restricted | ||
| 6267 | Taxol Janelia Fluor ® 549 | Aug 2020 |
| Yellow fluorescent taxol derivative; probe for microtubule staining | ||
| 7329 | Thalidomide 4'-ether-alkylC2-acid | Oct 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7330 | Thalidomide 4'-ether-alkylC3-acid | Sep 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7331 | Thalidomide 4'-ether-alkylC4-acid | Oct 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7332 | Thalidomide 4'-ether-alkylC5-acid | Sep 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7333 | Thalidomide 4'-ether-alkylC6-acid | Sep 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7334 | Thalidomide 4'-ether-alkylC7-acid | Sep 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7335 | Thalidomide 4'-ether-alkylC8-acid | Oct 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 6913 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine | Sep 2020 |
| Cereblon ligand with alkyl-PEG-alkyl linker and terminal amine for onward chemistry | ||
| 7288 | Thalidomide-Cyanine 5 | Sep 2020 |
| Fluorescent cereblon probe | ||
| 7350 | Tocriscreen Antiviral Library | Oct 2020 |
| Antiviral compound library for high throughput screening, chemical biology applications and drug repurposing; contains 240 bioactive compounds (100 μL 10 mM DMSO solutions) | ||
| 6261 | VCP 171 | Jan 2021 |
| Postitive allosteric modulator (PAM) of A1 receptors; also allosteric partial agonist in absence of orthosteric agonist | ||
| 7104 | VH 032 amide-PEG1-acid | Sep 2020 |
| VHL ligand with PEG linker and terminal acid for onward chemistry | ||
| 7105 | VH 032 amide-PEG5-acid | Nov 2020 |
| VHL ligand with PEG linker and terminal acid for onward chemistry | ||
| 7106 | VH 032 amide-alkylC2-acid | Oct 2020 |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7216 | VH 032 amide-alkylC3-acid | Dec 2020 |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7073 | VH 032 amide-alkylC3-amine | Dec 2020 |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | ||
| 7293 | VH 101 phenol-alkylC4-amine | Oct 2020 |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | ||
| 7294 | VH 101 phenol-alkylC6-amine | Oct 2020 |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | ||
| 7143 | VX 765 | Oct 2020 |
| High affinity and selective caspase-4 and caspase 1/ICE inhibitor; orally bioavailable | ||
| 7156 | WQ 1 | Dec 2020 |
| Potent and selective σ1 receptor antagonist; active in vivo | ||
| 7352 | YM 254890 | Jan 2021 |
| Gα-protein inhibitor; potent inhibitor of Gq/11 signaling | ||
| 7187 | Zanamivir | Aug 2020 |
| Potent influenza virus neuraminidase inhibitor | ||
| 6916 | dTAG-13-NEG | Aug 2020 |
| Negative control for dTAG-13 (Cat. No. 6605) | ||
| 6914 | dTAGV-1 | Aug 2020 |
| Potent and selective degrader of mutant FKBP12F36V fusion proteins | ||
| 7374 | dTAGV-1 hydrochloride | Jan 2021 |
| Hydrochloride salt of dTAGV-1 (Cat. No. 6914); suitable for in vivo use | ||
| 6915 | dTAGV-1-NEG | Aug 2020 |
| Negative control for dTAGV-1 (Cat. No. 6914) | ||
| 7303 | iHAP1 | Nov 2020 |
| Allosteric activator of protein phosphatase 2A (PP2A) | ||
| 7270 | iP300w | Jul 2020 |
| Potent p300/CBP inhibitor | ||
| 7298 | xStAx-VHLL | Sep 2020 |
| Selective peptide-based β-catenin degrader |